Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 16.52
+0.19 (1.16%)
May 16, 2025, 2:45 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 9.84 billion as of May 16, 2025. Its market cap has decreased by -26.49% in one year.
Market Cap
9.84B
Enterprise Value
6.84B
Revenue
1.12B
Ranking
n/a
PE Ratio
49.40
Stock Price
16.52
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 9.84B, a decrease of -65.02%. That is a compound annual growth rate of -27.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 9.84B | -5.60% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 325.75B |
| Shenzhen Mindray Bio-Medical Electronics | 281.76B |
| WuXi AppTec | 170.65B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.60B |
| Aier Eye Hospital Group | 121.89B |
| Shanghai United Imaging Healthcare | 113.80B |
| Sichuan Biokin Pharmaceutical | 106.93B |
| Yunnan Baiyao Group Co.,Ltd | 101.81B |